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60 The Journal of Thoracic and Cardiobjectives: The use of extracorporeal membrane oxygenation to support patients
ith shunted single-ventricle physiology has been controversial. Variable survivals
re reported in a number of small case series. We sought to evaluate outcomes and
dentify predictors of survival for patients with shunted single-ventricle physiology
ho require extracorporeal membrane oxygenation support.
ethods: We retrospectively reviewed the medical records of all patients aged less
han 1 year with shunted single-ventricle physiology who were supported with
xtracorporeal membrane oxygenation at Children’s Hospital Boston between 1996
nd 2005. Survivors and nonsurvivors were compared with respect to demographics,
iagnosis, operative variables, indication for extracorporeal membrane oxygenation,
nd extracorporeal membrane oxygenation variables.
esults: Forty-four infants with shunted single-ventricle physiology were supported
ith extracorporeal membrane oxygenation. Diagnoses included hypoplastic left
eart syndrome (24), other single-ventricle lesions (12), and pulmonary atresia/
ntact ventricular septum or a variant (8). Overall survival to discharge was 48%.
ndication for extracorporeal membrane oxygenation was the strongest predictor of
urvival to discharge, with 81% of patients cannulated for hypoxemia but only 29%
f those cannulated for hypotension surviving to discharge. Specifically, patients
annulated for shunt obstruction had the highest survival (83%).
onclusions: Overall survival to discharge for patients with shunted single-ventricle
hysiology is similar to survival reported in the Extracorporeal Life Support
rganization registry for all infants supported with cardiac extracorporeal mem-
rane oxygenation. Thus, shunted single-ventricle physiology should not be con-
idered a contraindication to extracorporeal membrane oxygenation. Patients can-
ulated for hypoxemia, particularly shunt thrombosis, had markedly improved
urvival compared with those supported primarily for hypotension/cardiovascular
ollapse. Survival did not differ depending on anatomic diagnosis.
enoarterial extracorporeal membrane oxygenation (ECMO) is commonly
used for circulatory support in pediatric cardiac surgical patients with
refractory low cardiac output, persistent hypoxemia, arrhythmias, cardiac
rrest, or failure to wean from cardiopulmonary bypass (CPB).1-4 Survival to
ospital discharge for pediatric patients receiving cardiac ECMO support reported to
he Extracorporeal Life Support Organization (ELSO) registry for 2004 was 41%.5
owever, the ELSO registry report and reports of ECMO outcomes from individual
nstitutions have shown considerable variability in survival because of the differ-
nces in anatomic diagnosis, surgical procedure, and ECMO indication. The vari-
vascular Surgery ● March 2007
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Dbility in outcomes may reflect differences in patient selec-
ion, timing of ECMO cannulation, and ECMO management.
arly reports of the use of cardiac ECMO suggested that
utcomes for patients with single-ventricle circulation are
ubstantially worse than those with 2-ventricle circula-
ion.6,7 On the basis of these reports, some centers have
onsidered single-ventricle circulation to be a relative con-
raindication to use of ECMO.7,8 However, more recent
tudies have reported survival as high as 64% in this group
f patients.9
The use of ECMO for the support of patients with
ortopulmonary shunts with or without systemic outflow
ract reconstruction (functionally univentricular circulation
ith an aortopulmonary shunt, which for simplicity will be
ermed “shunted single-ventricle circulation” throughout the
ext), such as after the Norwood procedure, poses a number
f unique problems beyond those experienced with ECMO
upport in patients with 2-ventricle circulation. There is an
ngoing need to balance systemic and pulmonary perfusion
n ECMO to prevent myocardial and systemic ischemia
aused by excessive runoff into the low-resistance pulmo-
ary bed through the shunt. In addition, the volume load
laced on the single ventricle may impair the recovery of
yocardial function after CPB. Some or all of these
actors may contribute to the increased morbidity and
ortality previously reported for ECMO support in these
atients.
The available literature regarding outcomes and risk fac-
ors for mortality in this patient population is limited by
mall patient numbers and lack of systematic review of
linical variables. Here we report the results of our experi-
nce with the use of ECMO for support of patients with
ingle-ventricle physiology with aortopulmonary shunts.
e sought to determine factors associated with survival to
ospital discharge in this high-risk group of patients sup-
orted with ECMO to identify subsets of patients most
Abbreviations and Acronyms
BT  Blalock–Taussig
CICU  cardiac intensive care unit
CPB  cardiopulmonary bypass
CPR  cardiopulmonary resuscitation
ECMO  extracorporeal membrane oxygenation
ELSO  Extracorporeal Life Support Organization
HLHS  hypoplastic left heart syndrome
IVS  intact ventricular septum
PA  pulmonary atresia
RVDCC right ventricle-dependent coronary
circulationikely to benefit from ECMO support. t
The Journal of Thoracicaterials and Methods
atients
e conducted a retrospective review of the ECMO database at
hildren’s Hospital Boston to identify all infants (1 year of age)
ith an aortopulmonary shunt with or without systemic or pulmo-
ary outflow tract reconstruction who were supported with ECMO
etween 1996 and 2005. Patients who had undergone the Norwood
rocedure with a right ventricle to pulmonary artery conduit rather
han a modified Blalock–Taussig (BT) shunt were excluded from
his study because we thought they represent a physiologically
ifferent group. We retrospectively reviewed medical records,
aily ECMO records, and cardiac catheterization and operative
eports to collect data on demographics, diagnoses, surgeries,
ndications for ECMO, details of ECMO course, and outcomes.
pproval for medical record review was obtained from the Chil-
ren’s Hospital Boston Committee on Clinical Investigation. The
eed for informed consent was waived.
xtracorporeal Membrane Oxygenation Management
irect intrathoracic cannulation was carried out for patients placed
n ECMO in the operating room after CPB and for those placed on
CMO in the cardiac intensive care unit (CICU) during the im-
ediate postoperative period. Patients who had not previously
ndergone median sternotomy or who were temporally remote
rom surgery were placed on ECMO support through the internal
ugular vein and common carotid artery. For patients placed on
CMO in the operating room or electively in the CICU, ECMO
as initiated using a blood-primed circuit. For patients requiring
rgent ECMO cannulation, such as during cardiopulmonary resus-
itation (CPR), a crystalloid-primed circuit, available in the CICU
t all times, was used. Patients cannulated during CPR had ice
acks placed around the head during resuscitation, and mild sys-
emic hypothermia (34.5°C–35.5°C) was maintained during the
rst 24 hours of ECMO support. After stabilization on ECMO,
iagnostic studies were undertaken to ascertain the reason for
eeding ECMO support. Diagnostic modalities, including echocar-
iography, cardiac catheterization, and mediastinal/shunt explora-
ion, were used as clinically indicated. The decision to investigate
nd choice of diagnostic modality, daily supervision of medical
are, and decisions regarding further therapeutic or surgical inter-
entions were at the discretion of the cardiac intensivist and
urgeon. Management of the ECMO circuit, including anticoagu-
ation and replacement of blood products, was conducted accord-
ng to institutional practice guidelines for the care of patients on
CMO.
The initial target for ECMO flow for all patients was 100 to 200
L/kg/min. Most patients were maintained on full flow for at least
4 hours after cannulation before attempts were made to wean
ows. Investigations for residual anatomic lesions were conducted
efore attempts to wean from ECMO support. For patients placed
n ECMO using a crystalloid-primed circuit, ultrafiltration was
sed to remove crystalloid volume, which was replaced with
acked red blood cells to increase the hematocrit to 35%. Contin-
ed use of ultrafiltration for management of intravascular volume
r to aid free water clearance was at the discretion of the cardiac
ntensivist.
Whenever possible, it was our practice to maintain shunt pa-
ency during ECMO support to reduce the risk of pulmonary
and Cardiovascular Surgery ● Volume 133, Number 3 661
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Dschemia-reperfusion injury and to avoid shunt thrombosis. How-
ver, in patients exhibiting decreased systemic perfusion or with
elayed clearance of lactate, despite increasing ECMO flows and
djusting sweep gases to augment systemic oxygen delivery, 1 or
ore surgical clips was placed to decrease the diameter of the
hunt and thus limit pulmonary blood flow.
ata Analysis
atients were categorized into 2 groups according to primary
ndication for ECMO: (1) those who underwent cannulation for
irculatory collapse (hypotension, failure to wean from CPB, or
ardiac arrest after profound hypotension) and (2) those who
nderwent cannulation for hypoxemia. For patients whose pre-
CMO period was characterized by both hypoxemia and hypoten-
ion, 2 authors (C. K. A. and R. R. T.) reviewed the physicians’
otes and intensive care unit charts and categorized patients into 1
f the 2 ECMO indication groups on the basis of consensus
pinion on which was the primary indication. Patients who were
uccessfully decannulated and survived to discharge were com-
ared with those who died with respect to demographic variables,
CMO indication, preoperative and operative variables, details of
he ECMO course, and complications. For patients who had 2 or
ore periods on ECMO, only data from the first ECMO run were
ncluded in the analysis.
Data were analyzed using the Statistical Package for the Social
ciences (SPSS v 12.0, Inc, Chicago, Ill). Continuous variables
ere compared using the Mann–Whitney test. Categoric variables
ere compared using the chi-square test, and the Fisher exact test
as used when the individual expected count in 1 or more cate-
ories was less than 5. In a multivariate logistic regression model,
e evaluated the association of ECMO indication and survival to
ospital discharge after adjusting for all other variables that were
ignificantly associated with survival.
esults
atient Demographics and Diagnoses
orty-four infants (15% of 283 cardiac ECMO uses during
he study period) with shunted single-ventricle circulation
nderwent 47 runs of ECMO support. Patient demographics
re summarized in Table 1. Hypoplastic left heart syndrome
HLHS) (n  24; 55%) was the most frequent diagnosis.
welve patients (27%) had non-HLHS single-ventricle
natomy, and 8 patients (18%) had pulmonary atresia (PA)
r a variant. All patients received ECMO support only
ostoperatively, except for 1 patient with HLHS and a
estrictive atrial septum who was placed on ECMO preop-
ratively after left atrial perforation during attempted atrial
eptostomy in the cardiac catheterization laboratory. This
atient also required ECMO support after a Norwood op-
ration for failure to wean from CPB. Because of the short
uration of preoperative support, only the postoperative
upport details were included in this analysis. Surgical pro-
edures performed included the Norwood operation in 29
atients (66%) and BT shunt placement without systemic
utflow reconstruction in 15 patients (34%), representing
0% of all Norwood procedures (n 288) and 8% of all BT c
62 The Journal of Thoracic and Cardiovascular Surgery ● Marchunts (n  179) performed in our institution during that
ime period. Of the 15 patients who underwent BT shunt
lacement without systemic outflow reconstruction, 9 pa-
ients underwent surgery with CPB (2 with significant hy-
oxemia or hemodynamic instability at the time of operation
nd 7 requiring additional surgical intervention) (Table 1). One
atient who underwent a Norwood operation for double
utlet right ventricle, complete atrioventricular canal, and
ABLE 1. Patient demographics
 44
ge (d) (median  SE) 8.0  2.3
eight (kg) 3.1 0.1
iagnoses: (n)
HLHS 24 (55%)
PA 8 (18%)
Critical PS (1)
PA/IVS (5)
PA/VSD/severe TR (1)
Ebstein’s/PA (1)
Non-HLHS single V 12 (27%)
DILV with systemic outflow obstruction (3)
DIRV/MA/PA (1)
DORV, unbalanced AVC, systemic outflow
obstruction (2)
DORV, unbalanced AVC, pulmonary
outflow obstruction (1)
Tricuspid atresia (3)
L-TGA/PA (1)
Truncus arteriosus, LV hypoplasia (1)
urgery
Stage I palliation 29 (66%)
BT shunt 15 (34%)
Additional procedures
RVOT patch 3
Pulmonary valvotomy 1
LPA plasty 1
Fenestrated TV closure, RA plication 1
Detachment of PAs from truncal root,
ETEA LPA and RPA
1
hunt size
3.0 mm 1
3.5 mm 41
4.0 mm 2
urgery on CPB 37 (84%)
otal CPB time (min) 129 15
irculatory arrest time (min) (n  26) 24  5
E, Standard error; HLHS, hypoplastic left heart syndrome; PS, pulmonary
tenosis; PA/IVS, pulmonary atresia/intact ventricular septum; VSD, ven-
ricular septal defect; TR, tricuspid regurgitation; DILV, double inlet left
entricle; DIRV, double inlet right ventricle; MA, mitral atresia; DORV,
ouble outlet right ventricle; AVC, atrioventricular canal; L-TGA, l-transpo-
ition of the great arteries; LV, left ventricle; BT, Blalock–Taussig; LPA, left
ulmonary artery; TV, tricuspid valve; RA, right atrium; PAs, pulmonary
rteries; ETEA, end-to-end anastomosis; RPA, right pulmonary artery; CPB,
ardiopulmonary bypass; RVOT, right ventricular outflow tract.oarctation of the aorta also underwent reimplantation of an
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Dnomalous left coronary artery arising from the pulmonary
rtery.
ndications for Extracorporeal Membrane
xygenation
atient characteristics and outcomes based on ECMO indi-
ation are shown in Table 1 and Figure 1. Twenty-eight
atients (64%) received ECMO support for circulatory col-
apse. Of these, 5 patients (11%) had failed to wean from
PB secondary to hypotension despite escalating inotropic
upport. Twenty-one patients were placed on ECMO sup-
ort for refractory low cardiac output (17) or sudden cardiac
rrest (4) in the CICU. ECMO support was initiated after
irculatory collapse secondary to tamponade in the remain-
ng 2 patients.
Sixteen patients (36%) received ECMO support for pro-
ound hypoxemia, 12 of whom had documented shunt ab-
ormalities on subsequent investigations. One patient had
Figure 1. Indication for cannulation and outcomes for
were supported with ECMO. ECMO, Extracorporeal meypoxemia secondary to preexistent pulmonary vascular t
The Journal of Thoracicisease that was unresponsive to conventional therapies
ncluding inhaled nitric oxide, and 3 patients had hypox-
mia secondary to parenchymal lung disease. Thirty-one
atients (70%) were receiving CPR during the initiation of
CMO support. ECMO support was initiated in the CICU in
he majority of patients (n  37; 84%).
etails of Extracorporeal Membrane Oxygenation
ourse and Patient Evaluation on Extracorporeal
embrane Oxygenation
he median duration of ECMO support was 125 hours
range 8-530 hours). The details of ECMO support for
urvivors and nonsurvivors are shown in Table 2.
valuation of Patients on Extracorporeal
embrane Oxygenation
chocardiography was the primary modality used to eval-
ate function and anatomy for patients on ECMO. In addi-
atients with shunted single-ventricle physiology who
ne oxygenation; CA, cardiac arrest.44 p
mbraion, all 10 patients cannulated for shunt thrombosis under-
and Cardiovascular Surgery ● Volume 133, Number 3 663
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Dent surgical shunt exploration at the time of ECMO
annulation, with shunt thrombus directly visualized in 9 of
0 patients. Thrombus was not seen in 1 patient, but suc-
ioning of the distal end of the shunt at the time of shunt
xploration led to a dramatic improvement in the pulmonary
erfusion, supporting the diagnosis of shunt thrombosis.
Fourteen patients underwent catheterization while on
CMO to investigate the cause of the event leading to
CMO or reason for inability to wean from ECMO. Cath-
terization diagnosed shunt narrowing in 1 patient and right
ubclavian artery stenosis in 2 patients, all of whom had
ypoxemia as an ECMO indication. Each of these patients
nderwent operative intervention based on catheterization
ABLE 2. Demographic, surgical, intraoperative, and ex-
racorporeal membrane oxygenation variables for survi-
ors versus nonsurvivors
Survivors (21)
(median  SE)
Nonsurvivors (23)
(median  SE) P
ge (d) 11.5 2.1 6 4.0 .55
eight (kg) 3.2 0.1 2.9  0.1 .17
iagnosis .09
HLHS 13 11
PA 1 7
Single ventricle,
non-HLHS
7 5
urgery .46
Stage I 15 14
BT shunt 6 9
hunt size/weight
(mm/kg)
1.09 0.05 1.21 0.05 .30
PB time (min) 129 15 108  22 .38
A time (min) (n  26) 25 5 15  7 .65
eak OR lactate 7.5 0.9 8.5  1.3 .40
ailed to wean from
CPB
2 (11%) 3 (15%) 1.00
ndication for ECMO .001
Hypoxemia 13 3
Hypotension 8 20
PR 13 (62%) 18 (78%) .33
ours on ECMO 114 15 160  23 .001
hunt clipped 4 (20%) 14 (61%) .007
eak ECMO lactate 11.6 1.9 13.5  1.4 .18
owest pH 7.18 0.03 7.22 0.04 .38
owest PO2 32  3 35  3 .01
UN 24 3 45  4 .001
reatinine 0.7 0.1 1.2  0.1 .001
ST 105 61 159  108 .001
LT 22  20 24  18 .27
E, Standard error; HLHS, hypoplastic left heart syndrome; PA, pulmonary
tresia; BT, Blalock–Taussig; CPB, cardiopulmonary bypass; CA, circula-
ory arrest; OR, operating room; CPR, cardiopulmonary resuscitation;
CMO, extracorporeal membrane oxygenator; BUN, blood urea nitrogen;
ST, aspartate aminotransferase; ALT, alanine aminotransferase.ndings, and all 3 successfully weaned from ECMO and P
64 The Journal of Thoracic and Cardiovascular Surgery ● Marcurvived to discharge. Catheterization was diagnostic in an
dditional 4 patients. Two with HLHS had left ventricle-
oronary fistulae and resulting myocardial ischemia. One
atient with severe Ebstein’s anomaly and PA who had
reviously undergone BT shunt placement and right ven-
ricular outflow tract patch had confirmation of a retrograde
ircular shunt. This patient underwent main pulmonary ar-
ery ligation but still failed to wean from ECMO. The fourth
atient with PA/intact ventricular septum (IVS) and right
entricle-dependent coronary circulation (RVDCC) had a
arge right ventricular thrombus impairing flow across the
ricuspid valve and therefore coronary perfusion.
hunt Management
urgical clips were placed on the BT shunt to limit pulmo-
ary blood flow in 17 of 44 patients (39%). Lactate clear-
nce was delayed (48 hours) for more patients who re-
uired shunt clipping than for those who had a patent shunt
hroughout ECMO (71% vs 39%, respectively). This differ-
nce approached statistical significance (P  .06). Fewer
urvivors than nonsurvivors had shunt clips placed (19% vs
7%, P  .011). As expected, more patients cannulated for
ardiovascular collapse versus hypoxemia required shunt
lipping (54% vs 6%, P  .024). Two patients cannulated
or hypoxemia required shunt clipping. One was a prema-
ure infant with hypoxemia secondary to lung disease of
rematurity who had excessive runoff through a 3.5-mm BT
hunt. The second was a 2.1-kg infant who required place-
ent of 3 clips on a 3.5-mm BT shunt to separate from
PB. Shunt thrombosis subsequently developed in this in-
ant, and after shunt thrombectomy, a single clip was placed
n the shunt to facilitate weaning from ECMO.
utcomes
hirty patients (68%) were successfully weaned from
CMO, and 21 patients (48%) survived to hospital dis-
harge. Table 2 summarizes the preoperative, operative, and
CMO variables for survivors versus nonsurvivors. Age,
eight, and type of surgery did not differ significantly
etween survivors and nonsurvivors, nor did BT shunt size
ormalized to patient weight (BT shunt size [millimeters]/
eight [kilograms]). For patients who underwent BT shunt
lacement without systemic outflow reconstruction, sur-
ival did not differ between those who underwent shunt
lacement on CPB or had additional surgical intervention at
he same time (eg, right ventricular outflow tract patch)
ersus those who did not. ECMO indication was signifi-
antly different between survivors and nonsurvivors, with
1% of patients cannulated for hypoxemia and only 29% of
hose cannulated for circulatory collapse surviving to dis-
harge (P  .001). Pre-ECMO minimum PAO2 was lower
or patients who survived to discharge (32 vs 36 mm Hg,
 .01), consistent with the fact that patients cannulated
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Dor hypoxemia had improved survival compared with those
annulated for circulatory collapse. BT shunt size normal-
zed to patient weight did not differ between those cannu-
ated for hypoxemia versus those cannulated for circulatory
ollapse (data not shown). The duration of ECMO support
as shorter (56  15 hours vs 160  23 hours, P  .001)
or survivors. The longest duration of ECMO support for a
urvivor not requiring transplantation was 303 hours com-
ared with 530 hours for nonsurvivors. The lowest pH
round the time of ECMO cannulation and maximum lac-
ate on ECMO did not differ between survivors and non-
urvivors. Indices of end-organ dysfunction on ECMO,
ncluding peak blood urea nitrogen, creatinine, and aspartate
minotransferase, were significantly lower for survivors
Table 2), although neither of these groups showed clini-
ally significant elevation of these laboratory parameters. In
multivariate logistic regression model, after adjustment
or variables significantly associated with survival in uni-
ariate analysis (blood urea nitrogen, creatinine, and
spartate aminotransferase), hypoxemia compared with
irculatory collapse as an indication for ECMO remained
ignificantly associated with survival to discharge (odds
atio for survival 10.8 [95% CI 1.2-99.9, P  .04]).
Although diagnosis did not differ significantly between
urvivors and nonsurvivors, there was a trend toward higher
ortality in patients with PA variants (P  .09). Survival
as 14% for patients with PA variants compared with 54%
or those with HLHS and 58% for those with non-HLHS
ingle-ventricle anatomy.
Among the 30 patients successfully weaned from
CMO, 3 who were initially cannulated for low cardiac
utput syndrome went on to require a second period of
CMO support during the same hospitalization. Indications
or second ECMO course included hypoxemia (shunt
hrombosis) (1), low cardiac output syndrome (1), and pro-
ressive renal and respiratory insufficiency (1). Two of
hese patients were successfully decannulated, and 1 patient
urvived to discharge.
eurologic Complications of Extracorporeal
embrane Oxygenation
ead ultrasounds were obtained on all infants as part of the
outine ECMO management protocol. Ten patients had ev-
dence of hemorrhage or infarct on head ultrasound. Nine of
hese patients did not survive to discharge, although man-
gement decisions were made on the basis of head ultra-
ound findings in only 1 of these patients. This infant with
arenchymal and intraventricular hemorrhage had ECMO
iscontinued because of head ultrasound findings and died
hortly thereafter despite maximal medical management.
idirectional Glenn and Fontan Completion
ollow-up data are available for patients who returned to
ur institution for further care. Twelve of 21 survivors have a
The Journal of Thoracicone on to Fontan completion; 4 patients have undergone
he bidirectional Glenn procedure, 3 of whom are await-
ng Fontan completion and 1 for whom further follow-up
ata are not available. One patient underwent transplan-
ation during the initial hospitalization and is alive today.
ne patient underwent conversion to a 2-ventricle circu-
ation and is alive at follow-up. Three patients died
efore the bidirectional Glenn procedure; 2 died suddenly
t home, and 1 died in hospice care with severe pulmo-
ary hypertension.
iscussion
n our study of 44 patients with shunted single-ventricle
irculation supported with ECMO, we show a 48% survival
o hospital discharge. We also show that indication for
CMO is significantly associated with survival to dis-
harge, with 81% of patients supported with ECMO for an
ndication of hypoxemia compared with 29% of those sup-
orted for cardiovascular collapse surviving to hospital
ischarge.
The use of ECMO to support patients with shunted
ingle-ventricle circulation has been controversial. Some
enters have successfully used prophylactic mechanical
upport without an oxygenator after the Norwood operation
o allow a period of myocardial recovery after CPB.10
owever, for patients with shunted single-ventricle circula-
ion who need urgent or semi-urgent ECMO support in the
ostoperative period, the literature provides conflicting data
s to whether mortality for these patients is comparable to
ortality for all patients supported with cardiac ECMO. Our
urvival to discharge of 48% is comparable to 41% cumu-
ative survival for all neonatal and pediatric cardiac ECMO
ases reported to the ELSO registry and to the cumulative
urvival to discharge of 53% for all patients supported with
ardiac ECMO in our institution (Peter Laussen, MBBS,
ersonal communication, 2005).
Cumulative survival for infants with HLHS who were
upported with ECMO reported to the ELSO registry be-
ween 1996 and 2000 is 28% and has not changed signifi-
antly over this time period.11 Survival at individual centers
as recently been reported to be from 31% to 61% survival
o discharge.2,9,12,13 Differences in survival likely reflect
ifferences between institutions in patient selection, indica-
ion for ECMO, timing of initiation of ECMO support,
CMO management, and availability of a rapid-response
CMO team. Center-specific case volume may impact sur-
ival as well, although there are no data in the literature to
upport this hypothesis. Higher survivals in our series may
eflect the high proportion of patients cannulated for ECMO
ith an easily reversible cause for decompensation, such as
hunt thrombosis or tamponade. Comparison of our analysis
nd previously published series is difficult, because survival
ccording to ECMO indication is not always reported. How-
and Cardiovascular Surgery ● Volume 133, Number 3 665
ev
o
C
s
s
r
E
p
p
p
n
c
p
c
r
o
p
c
a
s
s
l
E
v
s
a
f
a
s
a
q
s
o
f
e
t
s
p
o
(
c
p
h
o
t
p
t
s
s
u
s
c
p
t
o
t
t
b
f
t
b
t
p
w
i
E
n
p
g
t
t
p
t
H
i
l
n
s
t
f
a
p
c
L
T
a
e
a
C
S
s
w
f
c
i
o
s
n
Surgery for Congenital Heart Disease Allan et al
6
CH
Dver, in recent reports including patients with shunted single
entricle physiology supported with ECMO, the proportion
f patients supported with ECMO for failure to wean from
PB (37%-57%)12,13 was substantially higher than in our
eries (11%). The variation in the percentage of patients
upported with ECMO for failure to wean from CPB may
epresent the use of different criteria for patient selection for
CMO support, which may substantially influence outcomes.
Hypoxemia as the ECMO indication was the strongest
redictor of survival of all variables investigated. Among
atients supported for hypoxemia, those whose events were
recipitated by shunt-related problems (thrombosis or ste-
osis) had the best outcomes, with 83% surviving to dis-
harge. The more favorable outcome for this group of
atients compared with those supported with ECMO for
ardiovascular collapse is likely related to the acute and
eversible nature of the events precipitating clinical deteri-
ration. This subset of patients typically has a sudden and
recipitous clinical deterioration that can progress rapidly to
ardiac arrest. Our ability to rapidly cannulate for ECMO in
n urgent situation, including during CPR,1 allowed us to
tabilize these patients for diagnostic catheterization and/or
hunt thrombectomy. Once the shunt obstruction was re-
ieved, many of these patients could be easily weaned from
CMO because most patients in this group had preserved
entricular function.
Survival to discharge was significantly lower for patients
upported with ECMO for hypotension or sudden cardiac
rrest. This group represents a more diverse set of patients,
ew of whom had a discreet, easily reversible cause for their
rrest or deterioration, such as was the case for patients with
hunt thrombosis. Low cardiac output syndrome, cardiac
rrest, and inability to wean from CPB are the most fre-
uently cited indications for ECMO in patients with a
hunted single ventricle in the literature. Although a subset
f these patients may have CPB-related myocardial dys-
unction that will improve with myocardial rest, others have
ither irrecoverable myocardial dysfunction or physiology
hat will not allow weaning from mechanical support de-
pite an adequate technical repair. For example, 7 of 8
atients with PA or a variant did not survive to discharge in
ur series. Three of these patients had PA/IVS with RVDCC
1 patient with aortocoronary atresia), and significant myo-
ardial ischemia developed after BT shunt placement. These
atients with a baseline level of coronary ischemia may
ave further myocardial injury on ECMO because drainage
f the right atrium via the ECMO cannula may decompress
he right ventricle, thereby reducing coronary perfusion
ressure, possibly precluding weaning from ECMO. Pa-
ients with PA/IVS and RVDCC who are managed with
taged palliation have the highest risk of mortality after BT
hunt placement.14 Three patients with PA variants who
nderwent BT shunt and pulmonary outflow tract patch had v
66 The Journal of Thoracic and Cardiovascular Surgery ● Marcignificant pulmonary regurgitation resulting in a retrograde
ircular shunt and difficulty weaning from ECMO. These
atients, despite adequate technical repairs, had physiology
hat would not allow weaning from ECMO.
Of 13 patients catheterized in this study, only 4 had
perative interventions based on findings at catheterization
hat subsequently allowed weaning from ECMO support. Of
hese 4 patients, 3 survived to discharge, all of whom had
een cannulated for hypoxemia. The 1 patient cannulated
or circulatory collapse who underwent operative interven-
ion based on catheterization data was weaned from ECMO
ut did not survive to discharge. This also suggests that
echnically inadequate surgical results did not lead to ECMO in
atients supported for indication of circulatory collapse.
Previous reports of patients with a shunted single ventricle
ho were supported with ECMO have suggested that mortality
s higher among patients who have their shunt occluded on
CMO.9 Occlusion of all flow into the pulmonary arteries of
eonatal piglets undergoing CPB is associated with increased
ulmonary vascular resistance, increased alveolar-arterial O2
radients, and decreased pulmonary compliance.15 Other au-
hors have proposed that the increased mortality among pa-
ients who have complete shunt occlusion is related to
ulmonary injury from ischemia-reperfusion.16 We have
herefore avoided complete occlusion of the BT shunt.
owever, in the subset of patients who continue to have
nadequate systemic perfusion, as demonstrated by delayed
actate clearance despite increasing ECMO flows, we will
arrow the shunt using 1 or more surgical clips. In this
eries, significantly more nonsurvivors than survivors had
heir shunts clipped. However, we hypothesize that the need
or shunt clipping is a marker of severity of illness and is
ssociated with increased mortality for that reason. Shunt clip-
ing was required more frequently in patients cannulated for
ardiovascular collapse.
imitations
his study is limited primarily by its retrospective nature. In
ddition, generalizability of outcomes is limited by differ-
nces between institutions in the timing of ECMO initiation,
ttempts to wean from CPB, and ECMO management.
onclusions
urvival to discharge in this series of 44 patients with
hunted single-ventricle physiology who were supported
ith ECMO was 48%, comparable to the overall survival
or cardiac ECMO in our institution. Thus, we do not
onsider shunted single-ventricle physiology to be a contra-
ndication to ECMO support. The major determinant of
utcome in this series is the indication for ECMO, with
ignificantly greater survival to discharge for patients can-
ulated for hypoxemia. This likely reflects the readily re-
ersible nature of the cause for deterioration in the majority
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Df these patients. Mortality was higher among patients who
ad their shunts partially occluded, although this correlates
ith the indication for cannulation, suggesting that shunt
cclusion is a marker for severity of illness.
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